Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06672549 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Name: A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040) — clinical trial record (NCT06672549)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ADVANCE

StatusRecruiting

PhasePhase 3

SponsorEli Lilly and Company

Started2024-11-18

View on ClinicalTrials.gov ↗

The purpose of this pediatric, chronic weight management, Phase 3 Master Protocol (PWMP) is to create a framework to evaluate the safety and efficacy of pharmacologic agents for the treatment of obesity or overweight in pediatric participants.

Amendment history 3 changes detected by DataLookout

2026-08-25

Trial sites expanded: 104 → 117 locations

2026-07-21

Trial sites expanded: 50 → 104 locations

2026-04-21

Trial sites expanded: 41 → 50 locations

Trial Details

NCT Number	NCT06672549
Lead Sponsor	Eli Lilly and Company
Conditions	Obesity, Overweight
Enrollment	125 participants
Start Date	2024-11-18
Primary Completion	2027-02 (estimated)
Study Completion	2027-03 (estimated)
Updated on ClinicalTrials.gov	2026-08-24